azithromycin monohydrate
azithromycin monohydrate is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including Azithromycin, AZASITE. Available dosage forms: injection, powder, lyophilized, for solution, solution/ drops.
Drug details
- Generic Name
- azithromycin monohydrate
- Brand Names
- Azithromycin, AZASITE
- Application Number
- ANDA065501
- Sponsor
- Sagent Pharmaceuticals
- NDC Codes
- 6
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, SOLUTION/ DROPS
- Routes
- INTRAVENOUS, OPHTHALMIC
- Active Ingredients
- AZITHROMYCIN MONOHYDRATE
Indications and Usage
1 INDICATIONS AND USAGE Azithromycin for injection is a macrolide antibacterial drug indicated for the treatment of the following infections caused by designated susceptible microorganisms: • Community-acquired pneumonia in adults ( 1.1 ) • Pelvic inflammatory disease in adults ( 1.2 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs, azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. ( 1.3 ) 1.1 Community-Acquired Pneumonia Azithromycin for injection is indicated for the treatment of adult patients with community-acquired pneumonia due to the following susceptible microorganisms: Chlamydophila pneumoniae , Haemophilus influenzae , Legionella pneumophila , Moraxella catarrhalis , Mycoplasma pneumoniae , Staphylococcus aureus , or Streptococcus pneumoniae in patients who require initial intravenous therapy. 1.2 Pelvic Inflammatory Disease Azithromycin for injection is indicated for the treatment of adult patients with pelvic inflammatory disease due to the following susceptible microorganisms: Chlamydia trachomatis , Neisseria gonorrhoeae , or Mycoplasma hominis in patients who require initial intravenous therapy. If anaerobic microorganisms are suspected of contributing to the infection, an antimicrobial agent with anaerobic activity should be administered in combination with azithromycin for injection. 1.3 Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs, azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.